HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsuyoshi Kobayashi Selected Research

(3- aminooxalyl- 1- benzyl- 2- ethyl- 6- methyl- 1H- indol- 4-yloxy)-acetic acid methyl ester

5/2010Inhibition of secretory phospholipase A2 activity attenuates lipopolysaccharide-induced acute lung injury in a mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tsuyoshi Kobayashi Research Topics

Disease

49Neoplasms (Cancer)
02/2022 - 10/2003
47Hepatocellular Carcinoma (Hepatoma)
04/2022 - 04/2009
18Neoplasm Metastasis (Metastasis)
02/2022 - 03/2008
12Myocardial Infarction
04/2021 - 06/2006
9Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 05/2007
8Thrombosis (Thrombus)
12/2021 - 01/2011
8Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 09/2011
7Infections
05/2020 - 09/2005
6Reperfusion Injury
09/2022 - 06/2008
6Hemorrhage
03/2022 - 09/2004
6Fibrosis (Cirrhosis)
08/2021 - 05/2012
6Acute Cholecystitis
01/2021 - 12/2016
6Carcinoma (Carcinomatosis)
12/2015 - 03/2006
5Ischemia
09/2022 - 10/2007
5Cholangiocarcinoma
12/2021 - 12/2016
5Heart Failure
04/2021 - 05/2007
5Pathologic Constriction (Stenosis)
01/2018 - 02/2016
5Wounds and Injuries (Trauma)
01/2011 - 12/2003
5Urinary Bladder Neoplasms (Bladder Cancer)
08/2008 - 08/2003
4Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 07/2012
4Portal Hypertension
08/2021 - 06/2013
4Inflammation (Inflammations)
12/2020 - 08/2004
4Renal Cell Carcinoma (Grawitz Tumor)
01/2008 - 01/2002
3Liver Failure
10/2021 - 01/2015
3Carcinogenesis
08/2021 - 01/2014
3Infarction (Infarctions)
04/2021 - 10/2007
3Hepatic Encephalopathy
11/2020 - 03/2013
3Lymphoma (Lymphomas)
03/2020 - 04/2006
3Ascites
10/2019 - 01/2002
3Adenocarcinoma
10/2017 - 01/2009
3Cholecystitis
10/2017 - 08/2017
3Myocardial Ischemia (Ischemic Heart Diseases)
02/2009 - 05/2007
3Testicular Neoplasms (Testicular Cancer)
05/2008 - 11/2004
2Sepsis (Septicemia)
10/2022 - 08/2021
2Stomach Neoplasms (Stomach Cancer)
02/2022 - 01/2016
2Cysts
10/2021 - 12/2016
2Lymphatic Metastasis
04/2021 - 01/2018
2ST Elevation Myocardial Infarction
04/2021 - 07/2015
2Chronic Kidney Failure (Chronic Renal Failure)
01/2021 - 12/2007
2Anemia
01/2021 - 01/2010
2Edema (Dropsy)
12/2020 - 09/2007

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
11/2021 - 06/2006
6C-Reactive ProteinIBA
12/2020 - 05/2007
6Capsules (Microcapsules)IBA
02/2016 - 09/2009
5AdiponectinIBA
02/2009 - 06/2006
4AlbuminsIBA
12/2020 - 03/2017
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 08/2007
4Anti-Bacterial Agents (Antibiotics)IBA
01/2018 - 03/2002
4Secretory Phospholipases A2IBA
05/2011 - 06/2008
3lenvatinibIBA
04/2022 - 06/2020
3Bevacizumab (Avastin)FDA Link
04/2022 - 09/2018
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
02/2022 - 12/2016
3BilirubinIBA
10/2021 - 04/2011
3Antithrombin IIIIBA
10/2021 - 09/2012
3omega-Chloroacetophenone (Mace)IBA
04/2021 - 10/2017
3Antiviral Agents (Antivirals)IBA
12/2020 - 07/2019
3EnzymesIBA
08/2020 - 05/2003
3CholesterolIBA
01/2020 - 08/2010
3Lipoproteins (Lipoprotein)IBA
01/2020 - 01/2009
3rho-Associated KinasesIBA
06/2019 - 01/2012
3Tumor Biomarkers (Tumor Markers)IBA
01/2017 - 05/2008
3MetalsIBA
07/2015 - 03/2008
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2011 - 01/2010
3Adenosine Monophosphate (AMP)IBA
01/2009 - 05/2007
3Cisplatin (Platino)FDA LinkGeneric
08/2008 - 10/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2007 - 07/2006
2atezolizumabIBA
04/2022 - 10/2021
2Fetal Proteins (Fetoprotein)IBA
01/2022 - 06/2016
2Hepatitis B Surface Antigens (HBsAg)FDA Link
08/2021 - 03/2017
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2021 - 01/2020
2Hydroxyproline (4 Hydroxyproline)IBA
01/2021 - 04/2014
2Hormones (Hormone)IBA
01/2021 - 06/2006
2LipidsIBA
01/2021 - 01/2020
2Indicators and Reagents (Reagents)IBA
01/2021 - 11/2019
2IronIBA
01/2021 - 01/2010
2Immunosuppressive Agents (Immunosuppressants)IBA
12/2020 - 01/2017
2AntithrombinsIBA
11/2020 - 01/2019

Therapy/Procedure

41Hepatectomy
03/2022 - 04/2009
24Therapeutics
10/2021 - 08/2003
20Liver Transplantation
10/2022 - 05/2009
12Drug Therapy (Chemotherapy)
02/2022 - 11/2004
7Stents
01/2018 - 10/2007
5Splenectomy
08/2021 - 01/2011
5Chemoradiotherapy
08/2017 - 10/2003
5Nephrectomy
01/2008 - 10/2002
4Pancreaticoduodenectomy
03/2022 - 01/2018
4Percutaneous Coronary Intervention
04/2021 - 03/2008
4Laparoscopic Cholecystectomy
01/2021 - 12/2016
4Transplantation
12/2020 - 06/2013
4Ligation
03/2017 - 12/2007
4Cystectomy
08/2008 - 10/2003
3Renal Dialysis (Hemodialysis)
01/2021 - 10/2015
3Surgical Portasystemic Shunt (Portosystemic Shunt)
11/2020 - 03/2013
3Laparotomy
11/2020 - 10/2002
3Radiotherapy
06/2020 - 08/2008
3Segmental Mastectomy (Lumpectomy)
06/2020 - 08/2013
3Cholecystectomy
01/2019 - 08/2017
2Gastrectomy
02/2022 - 01/2016
2Immunotherapy
06/2021 - 01/2020
2Neoadjuvant Therapy
04/2021 - 09/2018